%0 Journal Article %A Hossein Gorji %A Noé Stauffer %A Ivan Lunati %A Alexa Caduff %A Martin Bühler %A Doortje Engel %A Ho Ryun Chung %A Orestis Loukas %A Sabine Feig %A Harald Renz %T Projection of Healthcare Demand in Germany and Switzerland Urged by Omicron Wave (January-March 2022) %D 2022 %R 10.1101/2022.01.24.22269676 %J medRxiv %P 2022.01.24.22269676 %X After the implementation of broad vaccination programs, there is an urgent need to understand how the population immunity affects the dynamics of the COVID-19 pandemic in presence of the protection waning and of the emergence of new vari-ants of concern. In the current Omicron wave that is propagating across Europe, assessing the risk of saturation of the healthcare systems is crucial for pandemic management, as it allows us to support the transition towards the endemic course of SARS-CoV-2 and implement more refined mitigation strategies that shield the most vulnerable groups and protect the healthcare systems. We investigated the current pandemic dynamics by means of compartmental models that describe the age-stratified social-mixing, and consider vaccination status, vaccine types, and their waning efficacy. Our goal is to provide insight into the plausible scenarios that are likely to be seen in Switzerland and Germany in the coming weeks and help take informed decisions. Despite the huge numbers of new positive cases, our results suggest that the current wave is unlikely to create an overwhelming health-care demand: owing to the lower hospitalization rate of the novel variant and the effectiveness of the vaccines. Our findings are robust with respect to the plausible variability of the main parameters that govern the severity and the progression of the Omicron infection. In a broader context, our framework can be applied also to future endemic scenarios, offering quantitative support for refined public health interventions in response to recurring COVID-19 waves.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been realized as a sub-project of B-FAST (Bundesweites Forschungsnetzwerk Angewandte Surveillance und Testung) for the joint project National Research Network of University Medicine on COVID-19, funded by the Federal Ministry of Education and Research (BMBF - FKZ 01KX2021).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll datasets used in this study are publicly available. The codes are available upon request from the corresponding author. %U https://www.medrxiv.org/content/medrxiv/early/2022/01/25/2022.01.24.22269676.full.pdf